Real-world observational study on pulmonary arterial hypertension: Italian cohort treated with macitentan and/or selexipag as a part of a combination treatment (INSPECTIO)
The INSPECTIO study supports the effectiveness of guideline-directed therapy and regular risk assessment to optimize treatment strategies in PAH. The increase in non-invasive low-risk criteria suggests a stabilization of disease over 12 months.
Authors
- Livio Giuliani
- Francesca Bux
- Fabiana Baldi
- Alessia Uglietti (ORCID: https://orcid.org/0000-0002-2929-3607)
- Stefano De Santis
- Marco Corda (ORCID: https://orcid.org/0000-0001-6477-4898)
- Paolo Ferrero
- Matteo Biancospino
- Edoardo Airò
- Pietro Ameri
- Laura Scelsi
- Michele D'Alto
- Marco Vicenzi
- Carlo D'Agostino
- Gavino Casu
- Piergiuseppe Agostoni
- Federico Guerra
- Roberto Badagliacca
- Gian Piero Perna
- Emma Di Poi
Institutions
- Università Cattolica del Sacro Cuore (IT)
- University of Verona (IT)
- Marche Polytechnic University (IT)
- Policlinico Umberto I (IT)
- Martin University (US)
- Agostino Gemelli University Polyclinic (IT)
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT)
- Centro Cardiologico Monzino (IT)
- San Salvatore Hospital (IT)
- Fatebenefratelli Hospital (IT)
- Azienda Ospedaliero Universitaria Ospedali Riuniti (IT)
- Ospedale Santa Maria della Misericordia di Udine (IT)
- Johnson & Johnson (Italy) (IT)
- Ospedale Policlinico San Martino (IT)
- Ospedale SS. Annunziata (IT)
- Policlinico San Matteo Fondazione (IT)
- Fondazione Toscana Gabriele Monasterio (IT)
- Polyclinic General Hospital (GR)
- Azienda Ospedaliera G. Brotzu (IT)
- University of Bari Aldo Moro (IT)
Publication Details
- Journal
- Vascular Pharmacology
- Published
- 2026-02-03
- DOI
- https://doi.org/10.1016/j.vph.2026.107585
- Primary Topic
- Pulmonary Hypertension Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00